{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:30:33Z","timestamp":1787697033932,"version":"build-2784847793"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Fertility preservation (FP) and monitoring has considerable relevance in the multidisciplinary approach to cancer patients. In these consensus-based practical recommendations, the scientific societies Fondazione Italiana Linfomi (FIL) and Societ\u00e0 Italiana della Riproduzione Umana (SIRU) reviewed the main aspects and identified the optimal paths which aim to preserve and monitor fertility in patients diagnosed with lymphoma at the different phases of the disease and during long-term survivorship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For the Panel, eleven experts were selected for their expertise in research and clinical practice on onco-fertility and lymphoma. The Panel\u2019s activity was supervised by a chairman. A series of rank-ordering key questions were proposed according to their clinical relevance and discussed among the Panel, focusing on patients diagnosed with non-Hodgkin\u2019s lymphomas and Hodgkin lymphoma. Agreement among all the Panelists on the content and terminology of the statements was evaluated by a web-based questionnaire according to the Delphi methodology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From the literature review a total of 78 questions or sentences, divided into the 6 areas of interest, were identified. By applying the Gwet's AC, k was: Section 1: 0,934 (Very good); Section 2: 0,958 (Very good); Section 3: 0,863 (Very good); Section 4: 0,649 (Good); Section 5: 0,936 (Very good); Section 6 raw agreement 100%. Two rounds of Delphi allowed to provide the maximum agreement. All statements were newly discussed in a round robin way and confirmed for the drafting of the final recommendations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These recommendations would be useful for onco-hematologists, gynecologists, urologists, and general practice physicians who take care of young lymphoma patients to guarantee an evidence-based oncofertility assessment and treatment during the oncologic pathway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1252433","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T04:30:22Z","timestamp":1694579422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi &amp; Societ\u00e0 Italiana della Riproduzione Umana"],"prefix":"10.3389","volume":"13","author":[{"given":"Carla","family":"Minoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Palini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Parissone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fedina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedro Alessandro","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"B1","volume-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2020"},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am JHematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/0300891620905649","article-title":"Management of lymphomasurvivorpatients in Italy: an evaluation by Fondazione Italiana Linfomi","volume":"107","author":"Minoia","year":"2021","journal-title":"Tumori"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.08.097","article-title":"Improving provision of care for long-term survivors of lymphoma","volume":"17","author":"Ciavarella","year":"2017","journal-title":"ClinLymphomaMyelomaLeuk"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Irvine DS.Fertility preservation for young patients with cancer: who is at risk and what can be offered","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05020-8","article-title":"Reproductive outcomes following a stem cell transplant for a haematological Malignancy in female cancer survivors: a systematic review and meta-analysis","volume":"27","author":"Gerstl","year":"2019","journal-title":"Support Care Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1439-0272.1995.tb01078.x","article-title":"Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey","volume":"27","author":"Marmor","year":"1995","journal-title":"Andrologia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830801)52:3<435::aid-cncr2820520308>3.0.co;2-1","article-title":"Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease","volume":"52","author":"Andrieu","year":"1983","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating aget exposure: a report from the childhood cancer survivor study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102981","article-title":"Novelaspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms","volume":"151","author":"Silvestris","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122881","article-title":"Male and female fertility: prevention and monitoring hodgkin' Lymphoma and diffuse large B-cell lymphoma adult survivors. A systematic review by the fondazione italianaLinfomi","volume":"13","author":"Viviani","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.3839","article-title":"Improving male reproductive health after childhood, adolescent, and young adult cancer: progress and future directions for survivorship research","volume":"36","author":"Kenney","year":"2018","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/03008916211040556","article-title":"Fertility preservation strategies for patients with lymphoma: a real-world practice survey among Fondazione ItalianaLinfomi centers","volume":"25","author":"Viviani","year":"2021","journal-title":"Tumori"},{"key":"B20","unstructured":""},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0257-x","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"McMillan","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi technique in health sciences: A map","volume":"22","author":"Niederberger","year":"2020","journal-title":"Front Public Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30818-6","article-title":"Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)","volume":"21","author":"Clark","year":"2020","journal-title":"Lancet Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31121","article-title":"Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"124","author":"Levine","year":"2018","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10815-017-1058-4","article-title":"Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR","volume":"35","author":"Pastore","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"FertilSteril"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-017-4594-3","article-title":"Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation","volume":"297","author":"Sch\u00fcring","year":"2018","journal-title":"Arch Gynecol Obstet."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500353877","article-title":"Fertility status among women treated for aggressive non-Hodgkin's lymphoma","volume":"47","author":"Elis","year":"2006","journal-title":"Leuk Lymphoma."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12877","article-title":"Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma","volume":"166","author":"Meissner","year":"2014","journal-title":"Br J Haematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000499535","article-title":"Gonadal function recovery and fertility in women treated with chemo- and\/or radiotherapy for hodgkin's and non-hodgkin lymphoma","volume":"64","author":"Gini","year":"2019","journal-title":"Chemotherapy"},{"key":"B33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/humrep\/deaa266","article-title":"Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study","volume":"36","author":"Pallotti","year":"2021","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1118476","article-title":"Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas","volume":"57","author":"Gharwan","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.08.014","article-title":"The effect of the Hyper-CVAD chemotherapy regimen on fertility and ovarian function","volume":"30","author":"Seshadri","year":"2006","journal-title":"Leuk Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.fertnstert.2012.07.1144","article-title":"Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation","volume":"98","author":"Blumenfeld","year":"2012","journal-title":"FertilSteril"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1517\/14740338.2011.527331","article-title":"Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective","volume":"10","author":"Bwire","year":"2011","journal-title":"Expert Opin Drug Saf."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.07.011","article-title":"Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence","volume":"48","author":"Mouyis","year":"2019","journal-title":"Semin Arthritis Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S154819","article-title":"Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era","volume":"10","author":"Traila","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.06.002","article-title":"Fertility and CAR T-cells: Current practice and future directions","volume":"28","author":"Ligon","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.11.032","article-title":"Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments","volume":"144","author":"Anderson","year":"2021","journal-title":"Eur J Cancer."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2020","article-title":"Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"van der Kaaij","year":"2007","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/hon.802","article-title":"Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy","volume":"25","author":"Hodgson","year":"2007","journal-title":"Hematol Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005557","article-title":"Hodgkin lymphoma and female fertility: a multicenter study in women treated with ABVD","volume":"21","author":"Machet","year":"2022","journal-title":"Blood Adv"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30500-X","article-title":"Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin\u2019slymphoma (RATHL): A secondary analysis of a randomised phase 3 trial","volume":"19","author":"Anderson","year":"2018","journal-title":"Lancet Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.138","article-title":"Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group","volume":"23","author":"Behringer","year":"2005","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-073544","article-title":"Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)","volume":"111","author":"Sieniawski","year":"2008","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn376","article-title":"Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials","volume":"19","author":"Sieniawski","year":"2008","journal-title":"Ann Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev310","article-title":"Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens","volume":"31","author":"Paoli","year":"2016","journal-title":"Hum Reprod"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02483-8","article-title":"ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma","volume":"23","author":"Amin","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0039","article-title":"cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity","volume":"102","author":"Francisco","year":"2003","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1200\/JCO.19.00315","article-title":"Nivolumab for newly diagnosed advanced-stage classic hodgkin lymphoma: safety and efficacy in the phase II checkMate 205 study","volume":"37","author":"Ramchandren","year":"2019","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac004","article-title":"PeccatoriF.Anti-Mullerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"24","author":"Anderson","year":"2022","journal-title":"HumReprod"},{"key":"B57","first-page":"40","volume-title":"Commission Directive 2006\/17\/EC of 8 February 2006 implementing Directive 2004\/23\/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells","year":"2006"},{"key":"B58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/uog.18945","article-title":"Counting ovarian antral follicles by ultrasound: a practical guide","volume":"51","author":"Coelho Neto","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2012.171","article-title":"Effects of oncological treatments on semen quality in patients with testicular neoplasia or lymphoproliferative disorders","volume":"15","author":"Di Bisceglie","year":"2013","journal-title":"Asian J Androl."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"FertilSteril"},{"key":"B61","unstructured":"Linee GuidaAIOM\n          (Associazione Italiana Oncologia Medica) Preservazione della fertilit\u00e0 nei pazienti oncologici Edizione2021"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/humrep\/deg163","article-title":"Testicular cancer and Hodgkin's disease: evaluation of semen quality","volume":"18","author":"Gandini","year":"2003","journal-title":"Hum Reprod"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa016","article-title":"Fertility preservation in boys: recent developments and new insights \u2020","volume":"2020","author":"Goossens","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)02264-1","article-title":"\"Onco-tese\": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines","volume":"61","author":"Schrader","year":"2003","journal-title":"Urology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.02.006","article-title":"FertiPROTEKT study group. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations","volume":"199","author":"von Wolff","year":"2016","journal-title":"Eur J ObstetGynecolReprod Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/uog.18934","article-title":"Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis","volume":"51","author":"Senra","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu036","article-title":"\u2018An ounce of prevention is worth a pound of cure\u2019: the case for and against GnRH-agonist for fertility preservation","volume":"25","author":"Blumenfeld","year":"2014","journal-title":"Ann Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S66600","article-title":"Fertility preservation and GnRHa for chemotherapy: debate","volume":"6","author":"Blumenfeld","year":"2014","journal-title":"Cancer Manag Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2016.1225713","article-title":"Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity","volume":"19","author":"Garrido-Oyarz\u00fan","year":"2016","journal-title":"Climacteric"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0700","article-title":"Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5","volume":"147","author":"Kitajima","year":"2006","journal-title":"Endocrinology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.08.011","article-title":"Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons","volume":"114","author":"Dolmans","year":"2020","journal-title":"FertilSteril"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008018.pub3","article-title":"Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women","volume":"3","author":"Chen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0028","article-title":"Survivorship, version 1.2021","volume":"19","author":"Tevaarwerk","year":"2021","journal-title":"J Natl ComprCancNetw."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1462e9","DOI":"10.1093\/humrep\/dez108","article-title":"Beyond fertility preservation: role of the oncofertilityunit in the reproductive and gynecological follow-up of youngcancer patients","volume":"34","author":"Massarotti","year":"2019","journal-title":"HumReprod"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12050","article-title":"Adult survivors of childhood cancer: the medical and psychosocial late effects of cancer treatment and the impact on sexual and reproductive health","author":"Jacobs","year":"2013","journal-title":"J Sex Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J Clin Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.11.045","article-title":"Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening","volume":"82","author":"Jain","year":"2004","journal-title":"FertilSteril"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr575","article-title":"Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial","volume":"23","author":"Behringer","year":"2012","journal-title":"Ann Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del188","article-title":"Assessment of ovarian reserve\u2014should we perform tests of ovarian reserve routinely","volume":"21","author":"Maheshwari","year":"2006","journal-title":"HumReprod"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.055","article-title":"Value of the day 3 follicle-stimulating hormone measurement","volume":"81","author":"Wolff","year":"2004","journal-title":"FertilSteril"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200406000-00005","article-title":"Assessment of ovarian reserve","volume":"16","author":"Bukulmez","year":"2004","journal-title":"CurrOpinObstetGynecol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"HumReprod Update"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.574263","article-title":"The clinical value and interpretation of anti-M\u00fcllerian hormone in women with cancer","volume":"11","author":"Anderson","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-M\u0308llerian hormone follow-up in young womentreated by chemotherapy for lymphoma: Preliminary results","volume":"20","author":"Decanter","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(98)70087-0","article-title":"The detection of diminished ovarian reserve in infertile women","volume":"179","author":"Sharara","year":"1998","journal-title":"Am J ObstetGynecol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab189","article-title":"Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling","volume":"36","author":"Decanter","year":"2021","journal-title":"Hum Reprod"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.fertnstert.2012.08.008","article-title":"Low concentration of circulating antim\u00fcllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study","volume":"98","author":"Hagen","year":"2012","journal-title":"FertilSteril"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00068","article-title":"Gonadal function recovery in patients with advanced Hodgkin lymphoma treated with a PET-adapted regimen: prospective analysis of a randomized phase III trial (AHL2011)","volume":"39","author":"Demeestere","year":"2021","journal-title":"J Clin Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/10245330600954072","article-title":"Ovarianfunctionaftercancer treatment in youngwomenaffected by Hodgkindisease (HD)","volume":"12","author":"Loverro","year":"2007","journal-title":"Hematology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu139","article-title":"The Bologna criteria for the definition of poor ovarian responders: is there a need for revision","volume":"29","author":"Ferraretti","year":"2014","journal-title":"Hum Reprod"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30156","article-title":"Stillbirth and neonatal death among female cancer survivors: a national cohort study","volume":"139","author":"Ji","year":"2016","journal-title":"Int J Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0029","article-title":"Birth outcomes among adolescent and young adult cancer survivors","volume":"3","author":"Anderson","year":"2017","journal-title":"JAMA Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202805","article-title":"Perinatal risks in female cancer survivors: a population-based analysis","volume":"13","author":"van der Kooi","year":"2018","journal-title":"PLoSOne"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31732","article-title":"Pregnancy after cancer: does timing of conception affect infant health","volume":"124","author":"Hartnett","year":"2018","journal-title":"Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.09.027","article-title":"Oocyte donation outcome after oncological treatment in cancer survivors","volume":"103","author":"Mu\u00f1oz","year":"2015","journal-title":"FertilSteril"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199708000-00006","article-title":"Gonadal function following ABVD therapy for hodgkin\u2019s disease","volume":"20","author":"Kulkarni","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30026-8","article-title":"Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","volume":"18","author":"Skinner","year":"2017","journal-title":"Lancet Oncol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"HumReprod Update"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900315)65:6<1303::aid-cncr2820650608>3.0.co;2-d","article-title":"Small testicles with impaired production of sperm in adult male survivors of childhood Malignancies","volume":"65","author":"Siimes","year":"1990","journal-title":"Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(85)90088-4","article-title":"Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD","volume":"21","author":"Viviani","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181377","article-title":"Follicle stimulating hormone is an accurate predictor of azoospermia in childhood cancer survivors","volume":"12","author":"Kelsey","year":"2017","journal-title":"PloS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1677\/joe.0.1620393","article-title":"Role of FSHin the regulation of spermatogenesis: clinical aspects","volume":"162","author":"Nieschlag","year":"1999","journal-title":"J Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(99)00222-1","article-title":"The roles of inhibin and related peptides in gonadal function","volume":"161","author":"De Kretser","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.9.8784094","article-title":"Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction","volume":"81","author":"Anawalt","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.1.5406","article-title":"Undetectable Inhibin B serum levels in men after testicular irradiation","volume":"84","author":"Petersen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1210\/jcem.82.12.4456","article-title":"Inhibin B as a serum marker of spermatogenesis: Correlation to differences in sperm concentration and follicle-stimulating hormone levels\u2014A study of 349 Danish men","volume":"82","author":"Jensen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032148","article-title":"Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men","volume":"89","author":"Andersson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23882","article-title":"Clinical application value of Inhibin B alone or in combination with other hormone indicators in subfertile men with different spermatogenesis status: A study of 324 Chinese men","volume":"35","author":"Kong","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.7038","article-title":"Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study","volume":"31","author":"Green","year":"2013","journal-title":"J Clin Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1829-y","article-title":"Pregnancy after breast cancer: case report and review of the literature","volume":"283","author":"Lawrenz","year":"2011","journal-title":"Arch Gynecol Obstet."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq198","article-title":"Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Pentheroudakis","year":"2010","journal-title":"Ann Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det430","article-title":"Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study","volume":"29","author":"van der Kaaij","year":"2014","journal-title":"Hum Reprod"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703421","article-title":"Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological Malignancies","volume":"29","author":"Chatterjee","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"B118","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/PPO.0b013e318198c758","article-title":"Sexuality after hematopoietic stem cell transplantation","volume":"15","author":"Yi","year":"2009","journal-title":"Cancer J"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0b013e31820955be","article-title":"Gynecologic care in hematopoietic stem cell transplant patients: a review","volume":"65","author":"Milroy","year":"2010","journal-title":"ObstetGynecolSurv"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0b013e3181dc1908","article-title":"Hematologic patients' clinical and psychosocial experiences with implanted long-term central venous catheter: self-management versus professionally controlled care","volume":"33","author":"M\u00f8ller","year":"2010","journal-title":"Cancer Nurs."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1188\/11.ONF.E351-E359","article-title":"Sexual well-being among survivors of non-Hodgkin lymphoma","volume":"38","author":"Beckjord","year":"2011","journal-title":"OncolNurs Forum."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1679","article-title":"Sexual functioning in long-term survivors of Hodgkin's lymphoma","volume":"19","author":"Recklitis","year":"2010","journal-title":"Psychooncology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bjc.2012.550","article-title":"Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group","volume":"108","author":"Behringer","year":"2013","journal-title":"Br J Cancer."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058768","article-title":"The quality of life of long-term survivors of Hodgkin's disease","volume":"5","author":"van Tulder","year":"1994","journal-title":"Ann Oncol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901410","article-title":"Inventories for male and female sexual dysfunctions","volume":"18","author":"Corona","year":"2006","journal-title":"Int J Impot Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01635.x","article-title":"Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction","volume":"7","author":"Isidori","year":"2010","journal-title":"J Sex Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24134","article-title":"Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology","volume":"115","author":"Jeffery","year":"2009","journal-title":"Cancer"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S380390","article-title":"Alliance against cancer (ACC) survivorship care and nutritional support working group. Cancer cure and consequences on survivorship care: position paper from the italian alliance against cancer (ACC) survivorship care working group","volume":"14","author":"Dal Maso","year":"2022","journal-title":"Cancer Manag Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1252433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T04:30:28Z","timestamp":1694579428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1252433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":131,"alternative-id":["10.3389\/fonc.2023.1252433"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1252433","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"article-number":"1252433"}}